US Patent Issued to Larimar Therapeutics, The United States of America, as represented by the Secretary, Department of Health and Human Services on March 3 for "Methods of quantifying frataxin and frataxin fusion proteins" (American, Canadian Inventors)

ALEXANDRIA, Va., March 3 -- United States Patent no. 12,566,178, issued on March 3, was assigned to Larimar Therapeutics Inc. (Bala Cynwyd, Pa.) and The United States of America, as represented by the Secretary, Department of Health and Human Services (Bethesda, Md.).

"Methods of quantifying frataxin and frataxin fusion proteins" was invented by Joan David Bettoun (Elkins Park, Pa.), Erik Johan Wagner (Sterling, Va.), Xin Xu (Potomac, Md.), Jean-Nicholas Mess (Laval, Canada) and Amy Qiu Wang (Poolesville, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides methods for determining the amount of FXN or FXN fusion protein in a sample, e.g., a tissue sample, by using mass spectrome...